HK Stock Market Move | IVD MEDICAL (01931) has risen by more than 13%, planning to spend over 3.1 billion Hong Kong dollars to acquire 20.31% of GOFINTECH QUANT, continuing to drive the RWA ecosystem to land.

IVD MEDICAL (01931) rose by over 13%, reaching a 13.31% increase at the time of publication, with a price of 10.98 Hong Kong dollars and a turnover of 456.534 million Hong Kong dollars. On the news front, IVD MEDICAL announced that its wholly-owned subsidiary, Final Touch Ltd., intends to conditionally agree to acquire 20.31% of GOFINTECH QUANT's shares held by the seller for approximately HK$3.142 billion, to be paid in the form of shares issued at the offer price. After the acquisition, IVD MEDICAL will become the major shareholder of the target company. This acquisition aims to strengthen capital synergies, promote the landing of the RWA ecosystem, establish an innovative cooperation network, enhance traditional financial endorsement, expand institutional cooperation foundations, jointly build a new ecosystem of blockchain finance, and support the globalization of Chinese assets. It is worth noting that since late July, IVD MEDICAL has continued to launch multiple key strategic initiatives. The company announced the globally pioneering "NewCo+RWA" exchange strategy and declared the issuance of IVDD stablecoin; it has pushed its U.S. subsidiary to apply for a stablecoin license, and jointly established the world's first "Innovative Drug Intellectual Property Tokenization Fund" with Huada, a subsidiary of BGI Genomics. On August 8th, IVD MEDICAL announced the formal launch of the "Global Enhanced Ethereum (ETH) Treasury" strategy, reached a strategic cooperation with HashKey, a licensed exchange in Hong Kong, and completed the initial purchase of 149 million Hong Kong dollars worth of ETH. Recently, the company has further sought shareholder approval for a 3 billion Hong Kong dollar ETH purchase authorization, to provide value anchoring and income feedback mechanisms for the construction of the medical innovation drug RWA trading platform ecosystem.